Pharmacodynamics of antibiotics to treat multidrug-resistant Gram-positive hospital infections (Q36777850)

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Nosocomial infections in the ICU: the growing importance of antibiotic-resistant pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Antibiotic usage and prescribing policies in the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Restrictive antibiotic policies are appropriate in intensive care units

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Strategies to prevent antimicrobial resistance in the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

The VISA/GISA problem: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Clinical pharmacokinetics of quinupristin/dalfopristin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Pharmacodynamics of fluoroquinolones against Streptococcus pneumoniae in patients with community-acquired respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Hyperlactacidemia potentially due to linezolid overexposure in a liver transplant recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Pharmacodynamics of glycopeptides in the mouse peritonitis model of Streptococcus pneumoniae or Staphylococcus aureus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

The pharmacokinetic and pharmacodynamic properties of vancomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Effects of prolonged vancomycin administration on methicillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteraemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Continuous versus intermittent infusion of vancomycin in severe Staphylococcal infections: prospective multicenter randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Pneumonia caused by oxacillin-resistant Staphylococcus aureus treated with glycopeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Adaptation of methicillin-resistant Staphylococcus aureus in the face of vancomycin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Effects of dosage, peak and trough concentrations in serum, protein binding, and bactericidal rate on efficacy of teicoplanin in a rabbit model of endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Retrospective review of serum teicoplanin concentrations in clinical trials and their relationship to clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Clinical pharmacokinetics of teicoplanin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Teicoplanin therapeutic drug monitoring in critically ill patients: a retrospective study emphasizing the importance of a loading dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

In vivo pharmacodynamics of a new oxazolidinone (linezolid)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Efficacy of linezolid plus rifampin in an experimental model of methicillin-susceptible Staphylococcus aureus endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Efficacy of linezolid in treatment of experimental endocarditis caused by methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Time-dependent antibacterial effects of linezolid in experimental rabbit endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Pharmacodynamic activity and efficacy of linezolid in a rat model of pneumococcal pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with Gram-positive infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Clinical pharmacodynamics of linezolid in seriously ill patients treated in a compassionate use programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

In vivo efficacy of continuous infusion versus intermittent dosing of linezolid compared to vancomycin in a methicillin-resistant Staphylococcus aureus rabbit endocarditis model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Outcome and attributable mortality in critically Ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Microbiological features of vancomycin in the 21st century: minimum inhibitory concentration creep, bactericidal/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Staphylococcus aureus isolates with reduced susceptibility to glycopeptides belong to accessory gene regulator group I or II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Analysis of vancomycin entry into pulmonary lining fluid by bronchoalveolar lavage in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Potential impact of vancomycin pulmonary distribution on treatment outcomes in patients with methicillin-resistant Staphylococcus aureus pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Methicillin-Resistant S. aureus Ventilator-Associated Pneumonia: Strategies to Prevent and Treat

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Pharmacokinetics and intrapulmonary concentrations of linezolid administered to critically ill patients with ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Clinical cure and survival in Gram-positive ventilator-associated pneumonia: retrospective analysis of two double-blind studies comparing linezolid with vancomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Teicoplanin in patients with acute leukaemia and febrile neutropenia: a special population benefiting from higher dosages

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Treatment of infections associated with surgical implants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Bacterial biofilms: a common cause of persistent infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Biofilms: survival mechanisms of clinically relevant microorganisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

An investigation of the antimicrobial effects of linezolid on bacterial biofilms utilizing an in vitro pharmacokinetic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Antibacterial activity of linezolid and vancomycin in an in vitro pharmacodynamic model of gram-positive catheter-related bacteraemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

The small colony variant (SCV) concept -- the role of staphylococcal SCVs in persistent infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Antimicrobial Treatment of Orthopedic Implant-related Infections with Rifampin Combinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Antimicrobial agents in orthopaedic surgery: Prophylaxis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Comparative efficacies of ciprofloxacin, pefloxacin, and vancomycin in combination with rifampin in a rat model of methicillin-resistant Staphylococcus aureus chronic osteomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

High dose vancomycin for osteomyelitis: continuous vs. intermittent infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Experience with outpatient intravenous teicoplanin therapy for chronic osteomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Linezolid therapy of vancomycin-resistant Enterococcus faecium experimental endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Penetration of linezolid into bone, fat, muscle and haematoma of patients undergoing routine hip replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Linezolid penetration into bone and joint tissues infected with methicillin-resistant staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Linezolid in the treatment of Gram-positive prosthetic joint infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

In vitro evaluation of the antibiotic lock technique (ALT) for the treatment of catheter-related infections caused by staphylococci.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Guidelines for the management of intravascular catheter-related infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Antibiotic lock with vancomycin and urokinase can successfully treat colonized central venous catheters in pediatric cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Antibiotic lock technique: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Antibiotic lock-technique for the treatment of catheter-related bloodstream infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Treatment of long-term intravascular catheter-related bacteraemia with antibiotic-lock therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Infections associated with medical devices: pathogenesis, management and prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Post-neurosurgical nosocomial bacterial meningitis in adults: microbiology, clinical features, and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Risk factors for adult nosocomial meningitis after craniotomy: role of antibiotic prophylaxis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Treatment of staphylococcal ventriculitis associated with external cerebrospinal fluid drains: a prospective randomized trial of intravenous compared with intraventricular vancomycin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Influence of dexamethasone on efficacy of ceftriaxone and vancomycin therapy in experimental pneumococcal meningitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Vancomycin versus teicoplanin in the therapy of experimental methicillin-resistant Staphylococcus aureus (MRSA) meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Cerebrospinal fluid penetration and pharmacokinetics of vancomycin administered by continuous infusion to mechanically ventilated patients in an intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Therapeutic vancomycin monitoring in children with hydrocephalus during treatment of shunt infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Antimicrobial therapy and local toxicity of intraventricular administration of vancomycin in a neonate with ventriculitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Staphylococcus aureus meningitis in adults: a clinical comparison of infections caused by methicillin-resistant and methicillin-sensitive strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Coagulase-negative staphylococcal meningitis in adults: clinical characteristics and therapeutic outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Meningitis due to methicillin-resistant Staphylococcus aureus (MRSA): review of 10 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Intraventricular administration of teicoplanin in shunt associated ventriculitis caused by methicillin resistant Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Cerebrospinal fluid linezolid concentrations in postneurosurgical central nervous system infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Pharmacokinetics of intravenous linezolid in cerebrospinal fluid and plasma in neurointensive care patients with staphylococcal ventriculitis associated with external ventricular drains

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Successful treatment and cerebrospinal fluid penetration of oral linezolid in a patient with coagulase-negative Staphylococcus ventriculitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Linezolid for the treatment of central nervous system infections in neurosurgical patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Clinical experience with linezolid for the treatment of central nervous system infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Successful treatment with linezolid and rifampicin of meningitis due to methicillin-resistant Staphylococcus epidermidis refractory to vancomycin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

A case of ventricular drainage infection with a rare pathogen in cerebrospinal fluid: vancomycin-resistant Enterococcus faecium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Efficacy of telavancin (TD-6424), a rapidly bactericidal lipoglycopeptide with multiple mechanisms of action, in a murine model of pneumonia induced by methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Inhibition of daptomycin by pulmonary surfactant: in vitro modeling and clinical impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Telavancin: in vitro activity against staphylococci in a biofilm model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Dalbavancin compared with vancomycin for prevention of Staphylococcus aureus colonization of devices in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Tolerability, pharmacokinetics, and serum bactericidal activity of intravenous dalbavancin in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Comparative efficacy of daptomycin and vancomycin in the therapy of experimental foreign body infection due to Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Daptomycin treatment of Staphylococcus aureus experimental chronic osteomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Use of daptomycin to treat drug-resistant Gram-positive bone and joint infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

In vitro activity of tigecycline against Staphylococcus epidermidis growing in an adherent-cell biofilm model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Comparative evaluation of tigecycline and vancomycin, with and without rifampicin, in the treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis in a rabbit model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Daptomycin is highly efficacious against penicillin-resistant and penicillin- and quinolone-resistant pneumococci in experimental meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

Efficacy of telavancin against penicillin-resistant pneumococci and Staphylococcus aureus in a rabbit meningitis model and determination of kinetic parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255

The phannacokinetics and extravascular diffusion of teicoplanin in rabbits and comparative efficacy with vancomycin in an experimental endocarditis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.255